Skip to main content
. 2019 Dec 13;42(4):636–644. doi: 10.1002/hed.26048

Table 1.

Demographic and clinical data of 128 studied patients with a TL in relation the development of hypothyroidism

All patients (128 patients) n (%) Hypothyroidism (69 patients) n (%) No hypothyroidism (59 patients) n (%)
Gender

Male

Female

113 (88.3)

15 (11.7)

58 (84.1)

11 (15.9)

55 (93.2)

4 (6.8)

Age Median (years), (SD) 66, (9.3) 64, (8.7) 69, (9.4)
Location tumor Hypopharynx 33 (25.8) 19 (27.5) 14 (23.7)
Larynx 95 (74.2) 50 (72.5) 45 (76.3)
T Classification T1 9 (7.0) 1 (1.4) 8 (13.6)

T2a larynx

T2b larynx

10 (9.4)

4 (3.1)

6 (8.7)

2 (2.9)

4 (6.8)

2 (3.4)

T2 hypopharynx 12 (9.4) 4 (5.8) 8 (13.6)
T3 33 (25.8) 18 (26.1) 15 (25.4)
T4 60 (46.9) 38 (55.1) 22 (37.3)
Treatment regimen

RT‐TL

TL‐RT

RT‐TL‐RT

51 (39.8)

55 (43.0)

22 (17.2)

25 (36.2)

30 (43.5)

14 (20.3)

26 (44.1)

25 (42.3)

8 (13.6)

RT field

Larynx only

Larger

16 (12.5)

112 (87.5)

6 (8.7)

63 (91.3)

10 (16.9)

49 (83.1)

(hemi)thyroidectomy Not performed 76 (59.3) 31 (44.9) 45 (76.3)
Performed 52 (40.6) 38 (55.1) 14 (23.7)
Neck dissection Not performed 32 (25.0) 16 (23.2) 16 (27.1)
Performed 96 (75.0) 53 (76.8) 43 (72.9)
Chemotherapy No concomitant chemotherapy 105 (82.0) 57 (82.6) 48 (81.3)
Concomitant chemotherapy with carboplatin/5‐FU 23 (18.0) 12 (17.4) 11 (18.7)

Abbreviations: 5‐FU, 5‐Fluorouracil; RT, radiotherapy; TL, total laryngectomy.